Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate
Clinical trial NCT05605964 · COMPLETED
Trial details
- NCT number
- NCT05605964
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-28
- Primary completion
- 2024-12-31
- Enrollment
- 387
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.